Ekso Bionics Maintains Buy Rating Despite Order Delays; Analyst Optimistic About Long-Term Prospects

Ekso Bionics, a Healthcare sector company, faces order delays, but analyst Swayampakula Ramakanth maintains a Buy rating due to strong financial position and strategic partnerships. Despite enterprise revenue decline, Ramakanth expects long-term growth. Partnerships with National Seating and Mobility and Bionic Prosthetics & Orthotics Group expanded the pipeline of potential customers, and the company's financial position supports operations into 2026.

Title: The 3D Printed Prosthetics Industry: A Growing Opportunity with Strong Financial Outlook

The 3D printed prosthetics industry is poised for significant growth, with a projected value of USD 3.1 billion by 2034, driven by a compound annual growth rate (CAGR) of 7.5% [1]. This rapid expansion is fueled by the increasing demand for personalized and affordable prosthetic solutions, technological advancements in 3D printing and materials, and the rising incidence of limb loss due to chronic conditions such as diabetes and vascular diseases.

The market is expected to reach USD 1.2 billion in the U.S. by 2034, underscoring the urgent need for advanced prosthetic solutions [1]. The integration of digital health innovations such as telehealth and remote patient scanning is creating fertile ground for the expansion of 3D printed prosthetics. These developments allow clinicians to deliver more accurate and timely care, contributing to broader adoption across the healthcare landscape.

Key players shaping the 3D printed prosthetics industry include YouBionic, WillowWood, Mercuris, Limbitless Solutions, Stratasys, Bionic Prosthetics and Orthotics, Create Prosthetics, UNYQ, Protosthetics, Prothea, Open Bionics, Eqwal Group (Steeper Group), Materialise, Exone, and Motorica. These companies are implementing strategic approaches to expand product customization, invest in research and development, and enhance digital workflows to streamline production and expand geographically [1].

Despite enterprise revenue decline, analyst Swayampakula Ramakanth maintains a Buy rating for Ekso Bionics due to its strong financial position and strategic partnerships. Partnerships with National Seating and Mobility and Bionic Prosthetics & Orthotics Group have expanded the pipeline of potential customers, and the company's financial position supports operations into 2026 [1]. This strong financial position is crucial for Ekso Bionics to navigate the challenges of order delays and maintain its market competitiveness.

The 3D printed prosthetics market is segmented by material, with polypropylene leading the market in 2024, generating USD 605.9 million, due to its favorable strength-to-weight ratio, fatigue resistance, and chemical stability [1]. The prosthetic clinics segment held a 46.1% share in 2024, benefiting from the efficiency of 3D printing in managing growing patient volumes and providing frequent replacements, especially for pediatric patients [1].

The global market for 3D printed prosthetics is expected to grow significantly over the next decade, driven by technological advancements, increasing demand for personalized solutions, and strategic partnerships. Companies in this sector are well-positioned to capitalize on these growth opportunities, provided they continue to innovate and adapt to the evolving healthcare landscape.

References:
[1] https://www.globenewswire.com/news-release/2025/08/06/3128563/28124/en/3D-Printed-Prosthetics-Industry-Worth-3-1-Billion-by-2034-Eyeing-7-5-CAGR-Through-2025-2034.html